[ExI] statins

Jason Resch jasonresch at gmail.com
Mon Sep 12 04:02:53 UTC 2016

A 2013 study on dangers and inefficacy of statins:


Cardio-vascular specialists have witnessed and actively participated in the
revolutionary developments that have occurred in their field of
specialization over the last few years. Cutting-edge technologies have led
to dramatic improvements in life-expectancy and quality of life. An
open-mind and pioneering attitude are necessary when exploring new
frontiers to improve our patients’ health. However, naïve indiscriminate
acceptance of novel mainstream therapies is not always advisable and
prudence is required in unearthing harmful, covert side effects. An
objective review of contemporary vascular research was performed and
industrial bias was sifted out for a fresh prospective on how to promote
primary cardiovascular prevention with attainable lifestyle adjustments
[1]. A comprehensive review of Pubmed, EMBASE and Cochrane review databases
was undertaken for articles relating to cardiovascular primary prevention
and statin side effects with the aim of harmonising their roles within
contemporary clinic practice. Particular attention was paid to large-scale
randomised controlled trials on contemporary cardiovascular
pharmacotherapies and their specific adverse effects on metabolic pathways
which feature prominently in cardiovascular primary prevention and
regenerative programmes. *There is a categorical lack of clinical evidence
to support the use of statin therapy in primary prevention. Not only is
there a dearth of evidence for primary cardiovascular protection, there is
ample evidence to show that statins actually augment cardiovascular risk in
women, patients with Diabetes Mellitus and in the young. Furthermore
statins are associated with triple the risk of coronary artery and aortic
artery calcification.* Cardiovascular primary prevention and regeneration
programmes, through life style changes and abstaining from tobacco use have
enhanced clinical efficacy and quality of life over any pharmaceutical or
other conventional intervention.

(emphasis added)


On Tue, Sep 6, 2016 at 11:32 AM, William Flynn Wallace <foozler83 at gmail.com>

> And there's a book by a physician that deals with nothing but the
> cognitive decline he says  is caused by statins.  No, I am not on it or a
> candidate for it.  So I am neutral.
> bill w
> http://www.peoplespharmacy.com/2016/09/05/doctors-deeply-
> divided-over-the-value-of-statins/?utm_source=The+People%27s+Pharmacy+
> Newsletter&utm_campaign=04667e26ff-This-Week-Email+9%
> 2F6%2F16&utm_medium=email&utm_term=0_7300006d3c-04667e26ff-
> 214968749&ct=t(This_Week_9_6_16)&mc_cid=04667e26ff&mc_eid=b9c6f5005a
> _______________________________________________
> extropy-chat mailing list
> extropy-chat at lists.extropy.org
> http://lists.extropy.org/mailman/listinfo.cgi/extropy-chat
-------------- next part --------------
An HTML attachment was scrubbed...
URL: <http://lists.extropy.org/pipermail/extropy-chat/attachments/20160911/bc748424/attachment.html>

More information about the extropy-chat mailing list